FDA grants approval for expanded use of Zykadia in first-line ALK-positive metastatic NSCLC May 29, 2017
FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma May 19, 2017
European Commission approves dinutuximab beta for the treatment of high-risk neuroblastoma May 11, 2017
RSS